首页 | 官方网站   微博 | 高级检索  
     

GP73在HBV相关性肝病中的水平及意义
引用本文:胡善雷,李广明,任 娜,许金生,高 鹏,李 琤. GP73在HBV相关性肝病中的水平及意义[J]. 天津医科大学学报, 2019, 0(6): 615-617
作者姓名:胡善雷  李广明  任 娜  许金生  高 鹏  李 琤
作者单位:(郑州市第六人民医院肝病科,郑州 450000)
摘    要:目的:探讨高尔基体蛋白73(GP73)在乙型肝炎病毒(HBV)相关性肝病中的检测及意义。方法:选取2016年5月-2018年5月在我院治疗的HBV相关性肝病患者160例,其中慢性乙肝患者78例,乙肝肝硬化患者52例,肝癌患者30例,采用GP73检测试剂盒检测血清GP73水平。结果:肝癌组、乙肝肝硬化组和慢性乙肝组血清GP73分别为(101.11±35.60)ng/mL、(81.87±30.54)ng/mL和(60.45±12.24)ng/mL,肝癌组>乙肝肝硬化组>慢性乙肝组>对照组(P<0.05);丙氨酸氨基转移酶(ALT)、天门冬氨酸转氨酶(AST)和总胆红素(TBIL)水平,肝癌组>乙肝肝硬化组>慢性乙肝组>对照组(P<0.05),而ALB水平,肝癌组<乙肝肝硬化组<慢性乙肝组<对照组(P<0.05);血清GP73与ALT、AST、TBIL成正相关(r=0.451、0.406和0.357,P<0.05),与ALB成负相关(r=-0.380,P<0.05)。结论: GP73在HBV相关性肝病中明显升高,与疾病严重程度和肝功能有一定关系。

关 键 词:高尔基体蛋白73  乙型肝炎病毒  肝癌  肝硬化

The level and significance of GP73 in HBV related liver diseases
HU Shan-lei,LI Guang-ming,REN Na,XU Jing-sheng,GAO Peng,LI Zheng. The level and significance of GP73 in HBV related liver diseases[J]. Journal of Tianjin Medical University, 2019, 0(6): 615-617
Authors:HU Shan-lei  LI Guang-ming  REN Na  XU Jing-sheng  GAO Peng  LI Zheng
Affiliation:(Depratment of Hepatology ,The Sixth People’s Hospital of Zhengzhou,Zhengzhou 450000,China)
Abstract:Objective: To investigate the detection and significance of Golgi protein 73 (GP73) in hepatitis B virus (HBV) related liver diseases. Methods: From May 2016 to May 2018,160 patients with HBV-related liver diseases were selected, including 78 patients with chronic hepatitis B, 52 patients with cirrhosis of hepatitis B and 30 patients with hepatocellular carcinoma, the serum GP73 level was detected by GP73 test kit. Results: The serum GP73 levels in hepatocellular carcinoma group, hepatitis B cirrhosis group and chronic hepatitis B group were (101.11±35.60) ng/mL, (81.87±30.54) ng/mL and (60.45±12.24) ng/mL, the serum GP73 levels in hepatocellular carcinoma group> hepatitis B cirrhosis group>chronic hepatitis B group>control group (P<0.05);alanineaminotransferase(ALT),aspartate aminotransferase (AST) and tumor bilirubin(TBIL) in hepatocellular carcinoma group>hepatitis B cirrhosis group>chronic hepatitis B group>control group (P<0.05), and ALB in hepatocellular carcinoma group<hepatitis B cirrhosis group<chronic hepatitis B group<control group (P<0.05); serum GP73 were positively correlated with ALT, AST and TBIL (r=0.451, 0.406 and 0.357, P<0.05), and negatively correlated with ALB (r=-0.380, P<0.05). Conclusion: GP73 are increased significantly in HBV related liver diseases, which are related to the severity of disease and liver function.
Keywords:Golgi protein 73  hepatitis B virus  liver cancer  cirrhosis
点击此处可从《天津医科大学学报》浏览原始摘要信息
点击此处可从《天津医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号